Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long‐term impairment of the GIP system

In patients with type 2 diabetes mellitus (T2DM), the insulinotropic action of the GIP system is desensitized, whereas this is not the case for the GLP‐1 system. This has raised an interesting discussion of whether GIP agonists or antagonists are most suitable for future treatment of T2DM together w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabe, Maria Buur Nordskov, van der Velden, Wijnand J. C., Gadgaard, Sarina, Smit, Florent Xavier, Hartmann, Bolette, Bräuner‐Osborne, Hans, Rosenkilde, Mette Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317972/
https://www.ncbi.nlm.nih.gov/pubmed/31299132
http://dx.doi.org/10.1111/bcpt.13289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317972/
https://www.ncbi.nlm.nih.gov/pubmed/31299132
http://dx.doi.org/10.1111/bcpt.13289

Ejemplares similares